The Spark
Clinical trials are evolving to meet the needs of patients and researchers alike. However, is the industry prepared to tackle emerging challenges in tech-enabled trials? In today's episode, our guest, Beth Hoffman, CEO of Origami Therapeutics, discusses these issues and gives insights on how they can be addressed. Listen to our latest podcast now for more info! Are you a sponsor looking for technology solutions to democratize your trials? Visit our website at https://www.castoredc.com/ for more information
10 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der The Spark-Community!